| ²é¿´: 882 | »Ø¸´: 0 | |||
seebio66666гæ (³õÈëÎÄ̳)
|
[½»Á÷]
¼ì²âÐÄÔàÊÜËð±êÖ¾ÎïELISAÊÔ¼ÁºÐ£¬ÓÃÓÚ¶¯ÎïÐÄѪ¹ÜÑо¿
|
|
¼ì²âÐÄÔàÊÜËð±êÖ¾ÎïELISAÊÔ¼ÁºÐ ÐÄÔàÊÜËðʱ¾Í»áÊÍ·ÅÐÄÔàÉúÎï±êÖ¾ÎﵽѪҺÖУ¬¼ì²âÉúÎï±êÖ¾ÎïµÄˮƽ¿ÉָʾÐÄÔàÊÜËðµÄ³Ì¶È¡£±êÖ¾Îï±ÈÈçÐ¡¸Æµ°°×-IÊÇרһÓÃÓÚ¼ì²âÐÄÔàÊÜËðµÄ±êÖ¾Î¶ø¼¡ºìµ°°×£¬Ö¬·¾Ëá½áºÏµ°°×ºÍMLC-1Éý¸ßÒ²ÊǹÇ÷À¼¡ÊÜËðµÄ½á¹û¡£ÔÚÈËÌåÖУ¬¼¡ºìµ°°×ºÍÖ¬·¾Ëá½áºÏµ°°×ÊǸßÓÚ»ùÏߵĵÚÒ»¸ö±êÖ¾ÎÐÄÔàÊÜËðºó2-4hÔö¼Ó¾Í¿ÉÒԲⶨ£¬9-12h´ïµ½¸ß·å£¬24-36hÓֻص½»ùÏß¡£Ð¡¸Æµ°°×-IÔÚ4-6h³¬¹ý»ùÏߣ¬12-24h´ïµ½¸ß·å£¬6-10ÌìÈÔÈ»»áÉý¸ß¡£ÎÒÃÇÒ»°ãµÄ¾ÑéÊǶ¯ÎïÐÄÔà±êÖ¾ÎïÔÚÊÜËð£¨1-2h£©¿ìËÙ´ïµ½¸ß·å£¬ÔÚ1-2ÌìÓֻص½»ùÏß¡£ ELISAÊÔ¼ÁºÐÏà¹Ø²úÆ·£º ELISA Kit(96-well kit) ·¶Î§ (ng/ml) ÖÐÎÄÃû³Æ ²úÆ·±àºÅ Mouse Cardiac Tn-I (for serum) 0.156 ¨C 10 СÊóÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0709A Mouse Cardiac Tn-I (for plasma) 0.156 ¨C 10 СÊóÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪ½¬£© ADM0710A Mouse Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 ¨C 2.5 СÊóÐ¡¸Æµ°°×-I ³¬ÁéÃôELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪ½¬»òѪÇ壩 ADM0711A Rat Cardiac Tn-I (for serum) 0.156 ¨C 10 ´óÊóÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0712A Rat Cardiac Tn-I (for plasma) 0.156 ¨C 10 ´óÊóÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪ½¬£© ADM0713A Rat Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 ¨C 2.5 ´óÊóÐ¡¸Æµ°°×-I ³¬ÁéÃôELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪ½¬»òѪÇ壩 ADM0714A Dog Cardiac Tn-I (for serum) 0.156 ¨C 10 ¹·Ð¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0715A Dog Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 ¨C 2.5 ¹·Ð¡¸Æµ°°×-I ³¬ÁéÃôELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪ½¬»òѪÇ壩 ADM0716A Pig Cardiac Tn-I (for serum) 0.039 ¨C 2.5 ÖíÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0717A Pig Cardiac Tn-I (for plasma) 0.039 ¨C 2.5 ÖíÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪ½¬£© ADM0718A Pig Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.0156 ¨C 1.0 ÖíÐ¡¸Æµ°°×-I ³¬ÁéÃôELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇå»òѪ½¬£© ADM0719A Monkey Cardiac Tn-I (for serum) 0.156 ¨C 10 ºïÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0720A Monkey Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.039 ¨C 2.5 ºïÐ¡¸Æµ°°×-I ³¬ÁéÃôELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇå»òѪ½¬£© ADM0721A Rabbit Cardiac Tn-I (for serum) 0.156 ¨C 10 ÍÃÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0722A RabbitCardiac Tn-I, Ultra Sensitive (for serum or plasma)1 0.0195 ¨C 1.25 ÍÃÐ¡¸Æµ°°×-I³¬ÁéÃô ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0723A Guinea Pig Cardiac Tn-I (for serum) 0.2 ¨C 12.5 ëàÊóÐ¡¸Æµ°°×-I ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0724A ELISA Kit £¨96-well kit£© ·¶Î§(ng/ml) ÖÐÎÄÃû³Æ ²úÆ·±àºÅ Mouse Myoglobin (for serum, plasma, & urine) 3.9 ¨C 250 СÊ󼡺쵰°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壬Ѫ½¬ºÍÄò£© ADM0726A Rat Myoglobin (for serum, plasma, & urine) 1.56 ¨C 100 ´óÊ󼡺쵰°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壬Ѫ½¬ºÍÄò£© ADM0727A Rabbit Myoglobin (for serum, plasma, & urine) 2 ¨C 125 Íü¡ºìµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壬Ѫ½¬ºÍÄò£© ADM0728A Dog Myoglobin (for serum, plasma, & urine) 3.9 ¨C 250 ¹·¼¡ºìµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壬Ѫ½¬ºÍÄò£© ADM0729A Pig Myoglobin (for serum, plasma, & urine) 0.5 ¨C 31.25 Öí¼¡ºìµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壬Ѫ½¬ºÍÄò£© ADM0730A Monkey Myoglobin (for serum, plasma, & urine) 2 ¨C 125 ºï¼¡ºìµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壬Ѫ½¬ºÍÄò£© ADM0731A Guinea Pig Myoglobin (for serum, plasma, & urine) 1.56 ¨C 100 ëàÊ󼡺쵰°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壬Ѫ½¬ºÍÄò ADM0732A ELISA Kit £¨96-well kit£© ·¶Î§ (ng/ml) ÖÐÎÄÃû³Æ ²úÆ·±àºÅ Mouse Cardiac FABP (for serum & urine) 0.31 ¨C 20 СÊóÐļ¡Ò¶Ëá½áºÏµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇåºÍÄò£© ADM0733A Rat Cardiac FABP (for serum & urine) 0.078 ¨C 5 ´óÊóÐļ¡Ò¶Ëá½áºÏµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇåºÍÄò£© ADM0734A Dog Cardiac FABP (for serum & urine) 0.31 ¨C 20 ¹·Ðļ¡Ò¶Ëá½áºÏµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇåºÍÄò£© ADM0735A Pig Cardiac FABP (for serum & urine) 0.78 ¨C 25 ÖíÐļ¡Ò¶Ëá½áºÏµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇåºÍÄò£© ADM0736A Rabbit Cardiac FABP (for serum & urine) 1.56 ¨C 100 ÍÃÐļ¡Ò¶Ëá½áºÏµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇåºÍÄò£© ADM0737A Monkey Cardiac FABP (for serum) 3.9 ¨C 250 ºïÐļ¡Ò¶Ëá½áºÏµ°°×ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇåºÍÄò£© ADM0738A ELISA Kit £¨96-well kit£© ·¶Î§ (ng/ml) ÖÐÎÄÃû³Æ ²úÆ·±àºÅ Rat & Mouse Cardiac MLC-1 (for serum) 0.078 ¨C 2.5 ´óÊó&СÊóÐ¡Çòµ°°×ÇáÁ´-1ELISAÊÔ¼ÁºÐ£¨ÓÃÓÚѪÇ壩 ADM0739A ʹÓÃÎÒÃǵ͝ÎA¸Æµ°°×-I,¼¡ºìµ°°×£¬Ö¬·¾Ëá½áºÏµ°°×ÊÔ¼ÁºÐ½á¹û¼ûÏÂͼ¡£Ñª½¬È¡×ÔÓÚÍÃÐÄÔà¾Ö²¿È±ÑªÇ°£¬È±ÑªÖм°ÔÙ¹à×¢ºó£¬ÏÂͼ¾ÍÌåÏÖ³ö¸÷×Ô±êÖ¾ÎïµÄˮƽ¡£ºÍÈ˵ÄÁÙ´²±íÏÖÏàͬ£¬¼¡ºìµ°°×ºÍÖ¬·¾Ëá½áºÏµ°°×ÔÚ¼¡¸Æµ°°×-IÔö¼Ó֮ǰÔö¼Ó£¬²¢ÇÒ¼¡¸Æµ°°×-I±È¼¡ºìµ°°×ºÍÖ¬·¾Ëá½áºÏµ°°×Ôö¼ÓµÄʱ¼äÒª³¤¡£ ÒÔÏÂΪ·¢±íµÄÎÄÏ×£º Mouse cTnI Publications Tajiri K, et al.Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther.[Epub ahead of print] (2013) Antoniak S, et al.PAR-1 contributes to the innate immune response during viral infection. J Clin Invest. [Epub ahead of print] (2013)http://www.jci.org/articles/view/66125 Butcher A, et al.An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated hearts. Pharmaceuticals. 6(4):546-556 (2013)http://www.mdpi.com/1424-8247/6/4/546 Taghiabadi E, et al.Protective effect of silymarin against acrolein-induced cardiotoxicity in mice. Evid Based Complement Alternat Med. 352091 (2012)http://www.hindawi.com/journals/ecam/2012/352091/ Foy KC, et al. Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer. OncoImmunology. 1(7):1-13 (2012) http://www.landesbioscience.com/journals/53/article/21057/ Zhang Y, et al. The comparison of ¦Á-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms. Int Immunopharmacol. 14(1):107-113 (2012) Bhushan S, et al. Selective ¦Â2-Adrenoreceptor Stimulation Attenuates Myocardial Cell Death and Preserves Cardiac Function After Ischemia-Reperfusion Injury. Arterioscler Thromb Vasc Biol. 32(8):1865-1874 (2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401356/ Predmore BL, et al. The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol. 302(11):H2410-8 (2012) De Meyer SF, et al. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood. [Epub ahead of print] (2012) Peart JN, See Hoe L, Pepe S, Johnson P and Headrick JP. Opposing effects of age and calorie restriction on molecular determinants of myocardial ischemic tolerance. Rejuvenation Res. 15(1):59-70 (2012) Kean TJ, et al. Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target. 20(1): 23-32 (2012) Xu Z, Desai M, Philip J, Sivsubramanian N,BowlesNEand Vallejo JG. Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-¦Â (TRIF) in the adult mouse heart is protective in acute viral myocarditis. Basic Res Cardiol. 106(6):1159-1171 (2011) Kiraly A, Koffman B, Hacker M, Gunning W, Rasche S, Quinn A. A novel aza-anthrapyrazole blocks the progression of experimental autoimmune encephalomyelitis after the priming of autoimmunity. Clin Immunol. 141(3):304-316 (2011) Ling Y, Pong T, Vassiliou CC, Huang PL and Cima MJ. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol. 29(3):273-277 (2011) Xu B, Strom J and Chen QM. Dexamethasone induces transcriptional activation of Bcl-xL gene and inhibits cardiac injury by myocardial ischemia. Eur J Pharmacol. 668(1-2):194-200 (2011) Braunersreuther V, et al. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. J Mol Cell Cardiol. 48(4):789-798 (2010) Haas MS, Alicot EM, Schuerpf F, Chiu I, Li J, Moore FD and Carrol MC. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovascular Research 87:618-627 (2010) Maas JE, Wan TC, Figler RA, Gross GJ and Auchampach JA. Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor. J Mole Cell Cardiol. 49(5):886-893 (2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958103/ Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C, Chen Q, Li J and Li Y. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischemia/reperfusion injury. Cardiovascular Research 84:442-451 (2009) Engle SK, et al. Qualification of cardiac troponin-I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development. Toxicologic Pathology 37:617-628 (2009) Qi D, Hu X. Wu X, Merk M, Leng L, Bucala R and Young LH. Cardiac Macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest. 119:3807-3816 (2009) Richer MJ, Lavall¨¦e DJ, Shanina I, Horwitz MS. Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection. PLoS ONE 4(1): e4127. doi:10.1371/journal.pone.0004127 (2009) Atkinson C., et al. Complement-dependent inflammation and injury in a murine model of brain dead donor hearts. Circulation Research. 105:1094-1101 (2009) Buyse MG, et al. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eurpoean Heart Journal 30:116-124 (2009) Elrod JW et.al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. PNAS 104:15560-15565 (2007) Eckle T, et al. Cardioprotection by Ecto-5¡ä-Nucleotidase (CD73) and A2B Adenosine Receptors. Circulation 115:1581-1590 (2007) Eckle T, et al. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ. Physiol. 291:H2533-H2540 (2006) Hardarson HS, et al. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ. Physiol 292:H251-H258 (2006) Madonna R, Rinaldi L, Rossi C, Geng Y-J and De Caterina R. Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. Clinical Research 27:2054-2061 (2006) Morrison RR, Tan XL, Ledent C, Mustafa SJ and Hifmann PA. Targeted deletion of A2Aadenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol. 293:H2523-H2529 (2007) Engle,SKet al. Strain differences in serum cardiac troponin-I concentration and myocardial necrosis after isoproterenol treatment in mice. Abstract No. 383. The Toxicologist CD ¡ª An official Journal of the Society of Toxicology, Volume 96, Number S-1 (2007) Hou G, Dick R, Zeng C, Brewer GJ. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models. Translational Research 148:309-314 (2006) Huber SA, Feldman AM and Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-a transgenic mice. Circ Res. 99:1109-1116 (2006) Mullick A, Leon Z, Min-Oo G, Berghout J, Lo R, Daniels E and Gros P. Cardiac failure in C5-deficient mice after Candida albicans infection. Infection and Immunity. 74(8):4439-4451 (2006)Hou G, Dick R, Abrams GD, Brewer GJ., Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice. J Lab Clin Med.146(5):299-303 (2005Tao L, Liu H-R, Gao F, Qu Y, Christopher TA, Lopez BL and Ma XL. Mechanical traumatic injury without circulatory shock causes cardiomyocyte apoptosis: rol of reactive nitrogen and reactive oxygen species. Am J Heart Circ Physiol. 288:H2811-H2818 (2005) Rat cTnI Publications Yeh CH, et al.Potent cardioprotection from ischemia-reperfusion injury by a 2-domain fusion protein comprising Annexin V and Kunitz protease inhibitor.J Thromb Haemost.doi: 10.1111/jth.12314 (2013) Doods H and Wu D.Sabiporide reduces ischemia-induced arrhythmias and myocardial infarction and attenuates ERK phosphorylation and iNOS induction in rats. BioMed Res Int. 2013:504320 (2013)http://www.hindawi.com/journals/bmri/2013/504320/ Ke D, Fang J, Fan L, Chen Z, Chen L.Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.Coron Artery Dis. [Epub ahead of print] (2013) Watts JA, Gellar MA,FulkersonMB, Kline JA.A soluble guanylate cyclase stimulator, BAY 41-8543, preserves right ventricular function in experimental pulmonary embolism.Pulm Pharmacol Ther. [Epub ahead of print] (2012) Cheng K, et al. Magnetic enhancement of cell retention, engraftment and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21(6):1121-1135 (2012) http://www.ingentaconnect.com/content/cog/ct/2012/00000021/00000006/art00006 Juneman EB, Saleh L, Lancaster JJ, Thai HM,MarkhamB and Goldman S. The effects of poloxamer-188 on left ventricular function in chronic heart failure after myocardial infarction. J Cardiovasc Pharmacol. 60(3):293-298 (2012) Govindan S, et al. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol. 52(1):154-164 (2012) Huang CH, et al. Acute cardiac dysfunction after short-term diesel exhaust particles exposure. Toxicol Lett. 192(3):349-355 (2012) Shin IW, et al. Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol. 61(6):499-505 (2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249573/ Li T, et al. Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol. 39(6):392-397 (2011) Zisa D, et al. Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol Heart Circ Physiol. 301(6):H2422-2432 (2011) Shin IW, et al. Propofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol. 58(4):378-382 (2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876860/ Todorova VK, Kaufman Y, Hennings LJ and Klimberg VS. Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats. Cancer Chemother Pharmacol 66:315-323 (2010) Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y and Iwai N. Plasma miR-208 as a Biomarker of Myocardial Injury. Clin Chem. 55(11):1944-1949 (2009) Yue T-L, et.al. In vivo activation of peroxisome proliferator-activated redeptor-d protects the heart from ischemia/reperfusion injury in Zucker fatty rats. J. Pharm. Exp. Ther. 325:466-474 (2008) Zagorski J, Gellar MA, Obraztsova M, Kline JA andWattsJA. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. The Journal of Immunology 179:7820-7826 (2007) Legare JF, Oxner A, Heimrath O, Myers T and Currie RW. Heat Shock treatment results in increased recruitment of labeled PMN following myocardial infarction. Am J Physiol Heart Circ Physiol. 293(5):H3210-5 (2007) Chopra M and Sharma AC. Distinct cardiodynamic and molecular chracteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sciences. epub. July 2007 Liu J, Pang Y, Chang T, Bounelis P,ChathamJC, and Marchase RB. Increased hexoseamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol. Cell Cardiol. 40 303-312 (2006) Wang P and Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286:E725-E736 (2004) Rabbit cTnI Publications Booth EA, and Lucchesi BR. Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 293(3):H1408-15 (2007) Lauver DA, Booth EA, White AJ, Poradosu E & Lucchesi BR. Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharm. Exp. Ther. 312(2):794-800 (2005) Lauver DA, Lockwood SF and Lucchesi BR. Disodium disuccinate astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J Pharm. Exp. Ther. 314(2):686-692 (2005) Booth EA, Obeid NR and Lucchesi BR. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 289(5):H2039-47 (2005) Pig cTnI Publications Uitterdijk A, et al.Serial measurement of hFABP and high sensitivity Troponin I post PCI in STEMI. How fast and accurate can Myocardial Infarct Size and No-Reflow be predictedAm J Physiol Heart Circ Physiol. [Epub ahead of print] (2013) Wu D, Kraut J, and Abraham WM.Sabiporide improves cardiovascular function, decreases the inflammatory response and reduces mortality in acute metabolic acidosis in pigs. PLoS one. 8(1): e53932 (2013)http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0053932 Wu D and Qi J. Mechanisms of the beneficial effect of NHE1 inhibitor in traumatic hemorrhage: inhibition of inflammatory pathways. Resuscitation. 83(6):774-781 (2012) Gill RS, et al. Cyclosporine treatment improves cardiac function and systemic hemodynamics during resuscitation in a newborn piglet model of asphyxia: a dose-response study. Crit Care Med. 40(4): 1237-1244 (2012) Bebarta VS, et al. Hydroxocobalamin and Epinephrine Both Improve Survival in a Swine Model of Cyanide-Induced Cardiac Arrest. Ann Emerg Med. [Epub ahead of print] (2012) Wu D, Qi J, Dai H, Doods H and Abraham WM. Resuscitation with Na+/H+ exchanger inhibitor in traumatic haemorrhagic shock: cardiopulmonary performance, oxygen transport and tissue inflammation. Clin Exp Pharmacol Physiol. 37(3):337-342. (2010) Liu J-Q, Lee T-F, Bigam DL and Cheung P-Y. Effects of post-resuscitation treatment with N-acetylcysteine on cardiac recovery in hypoxic newborn piglets. PLoS one 5(12): e15322 (2010) Osipov RM, et al. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interactive CardioVascular and Thoracic Surgery 10: 506-512 (2010) Adams JA, et al. Periodic acceleration (pGz) prior to whole body ischemia reperfusion injury provides early cardioprotective preconditioning. Life Sciences 86: 707-715 (2010) Wu D, Bassuk J, Arias J, Doods H andAdamsJA. Cardiovascular effects of Na+/H+ exchanger inhibition with BIIB513 following hypovolemic circulatory shock. Shock 23(3):269-274 (2005) Monkey cTnI Publications Minimo H, et al. Characteristics of troponins as myocardial damage biomarkers in cynomolgus monkeys. J Toxicol Sci. 34(6): 589-601 (2009) Mouse Myoglobin Publications Nogales-Gadea G, et al. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain. 135(Pt 7): 2048-2057 (2012) Ling Y, Pong T, Vassiliou CC, Huang PL, Cima MJ. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol. 29(3):273-277 (2011) Rat Myoglobin Publications Ohta M, Kawano H, Notsu T, Naba H and Imada K. Eicosapentaenoic acid attenuates statin-induced ER stress and toxicity in myoblast. Biochem Biophys Res Commun. 424(2):301-307 (2012) Kerkweg U, Pamp K, Fieker J, Petrat F, Hider RC and de Groot H. Release of redox-active iron by muscle crush trauma: no liberation into the circulation. Shock. 33(5):513-518 (2010) http://journals.lww.com/shockjournal/Fulltext/2010/05000/Release_of_Redox_Active_Iron_By_Muscle_Crush.11.aspx Ó¦ÓÃÉùÃ÷£ºËùÓвúÆ·½öÓÃÓÚ¿ÆÑУ¬²»ÄÜÓ¦ÓÃÓÚÕï¶ÏºÍÖÎÁÆ¡£ ÆäËû²úÆ·£º ¼±ÐÔʱÏà·´Ó¦´¿»¯µ°°×ºÍ¿¹Ì壬Ñо¿¼±ÐÔÑ×Ö¢ÐÔ¼²²¡ Ñо¿¸Î²¡£¬¸ÎÖж¾ELISAÊÔ¼ÁºÐºÍ´¿»¯µ°°× ¼ì²â¼±ÐÔʱÏà·´Ó¦µ°°×ELISAÊÔ¼ÁºÐ£¬Ñо¿¼±ÐÔÑ×Ö¢ÐÔ¼²²¡ ¼ì²âÃâÒßÇòµ°°×ELISAÊÔ¼ÁºÐ ÐÄѪ¹ÜÑо¿ÓÃÐÄÔà±êÖ¾ÎÌå ÐÄѪ¹ÜÑо¿ÓÃÐÄÔà±êÖ¾Îï´¿»¯µ°°× ¼ì²âÐÄÔàÊÜËð±êÖ¾ÎïELISAÊÔ¼ÁºÐ£¬ÓÃÓÚ¶¯ÎïÐÄѪ¹ÜÑо¿ ¹Ç÷À¼¡ÊÜËð±êÖ¾Îï¼ì²âÊÔ¼ÁºÐ ´¿»¯µÄ¹Ç÷À¼¡±êÖ¾Îï Ñо¿ÉúÎï¼¼ÊõÒ©ÎïµÄÃâÒß¶¾ÐÔELISAÊÔ¼ÁºÐ |
» ²ÂÄãϲ»¶
Áôѧ--²©Ê¿ÕÐÉú
ÒѾÓÐ16È˻ظ´
»¯Ñ§¹¤³Ì£¬±¾211£¬Çóµ÷¼Á£¬abÇø²»ÏÞ
ÒѾÓÐ4È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ276È˻ظ´
ºþ±±Ê¦·¶´óѧÕе÷¼ÁÀ²
ÒѾÓÐ9È˻ظ´
ÉÛÑôѧԺʳƷÓ뻯ѧ¹¤³ÌѧԺ˶ʿµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ìì½òÉÌÒµ´óѧ ÉúÎïÓëÒ½Ò©¿ÎÌâ×éÕÐÉú
ÒѾÓÐ0È˻ظ´
ÉúÎﻯ¹¤Ñ§Ë¶ÕÐÊÕµ÷¼Á
ÒѾÓÐ0È˻ظ´
¹ã¶«Ê¯ÓÍ»¯¹¤Ñ§Ôº2026Äê˶ʿÑо¿ÉúÐèÒª¶àÃûÉúÎï£¬ÖÆÒ©¹¤³Ì£¬Ê³Æ·×¨ÒµµÄµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
317·Ö Ò»Ö¾Ô¸½ÄÏ´óѧ »¯Ñ§¹¤³Ìѧ˶ Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
»¯¹¤É격
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
ÕÒµ½Ò»Ð©Ïà¹ØµÄ¾«»ªÌû×Ó£¬Ï£ÍûÓÐÓÃŶ~
СÊóELISAºÍÁ÷ʽϸ°ûʵÑéÎÊÌâÇóÖú
ÒѾÓÐ8È˻ظ´
Ö²ÎïÒÒõ£¸¨Ã¸AôÈ»¯Ã¸(ACC)¶¨Á¿¼ì²âÊÔ¼ÁºÐ£¨ELISA£© ÖÐÎÄ˵Ã÷Êé
ÒѾÓÐ13È˻ظ´
ÇóÖú£¬LPS´Ì¼¤RAW264.7ÓÃELISAÊÔ¼ÁºÐ¼ì²âTNF-¦ÁºÍIL-6Ôõô×ö
ÒѾÓÐ7È˻ظ´
ELISAÊÔ¼ÁºÐʹÓÃ
ÒѾÓÐ4È˻ظ´
ÓÃELISAÊÔ¼ÁºÐ²âÑ×Ö¢Òò×ÓµÄÎÊÌâ
ÒѾÓÐ6È˻ظ´
ÇëÎÊELISAÓõÄ96¿×°åÊÔ¼ÁºÐµÄ¿×¾¶¶à´ó£¿
ÒѾÓÐ4È˻ظ´
elisaÊÔ¼ÁºÐ¼ì²âÃâÒßÒò×ÓµÄÏà¹ØÎÊÌâ
ÒѾÓÐ9È˻ظ´
¡¾ÇóÖú¡¿ELISA ¼ì²âÊÔ¼ÁºÐÀïø±ê׼ƷϡÊÍÒºÊÇʲô³É·Ö
ÒѾÓÐ10È˻ظ´
¡¾½»Á÷¡¿É¢½ð±ÒÌÖÂÛ´ó¼ÒElisaÊÔ¼ÁºÐ¶¼ÓõÄÄĸö¹«Ë¾µÄ
ÒѾÓÐ4È˻ظ´
¿ÆÑдÓСľ³æ¿ªÊ¼£¬ÈËÈËΪÎÒ£¬ÎÒΪÈËÈË













»Ø¸´´ËÂ¥

µã»÷ÕâÀïËÑË÷¸ü¶àÏà¹Ø×ÊÔ´